Search

Filter by:
Page 1 of 1034 // 10332 Results found

Data

Combined indicator: 14-day notification rate, testing rate and test positivity, updated 5 August 2021 (colour-blind friendly), weeks 29-30

Map -

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU.

Data

Combined indicator: 14-day notification rate, testing rate and test positivity, updated 5 August 2021, weeks 29-30

Map -

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU.

Data

14-day case notification rate per 100 000 inhabitants, updated 5 August 2021, weeks 29-30

Map -

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU.

Data

Testing rates per 100 000 inhabitants, updated 5 August 2021, week 30

Map -

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU.

Data

Positivity rates, updated 5 August 2021, week 30

Map -

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU.

Data

Data on the daily number of new reported COVID-19 cases and deaths by EU/EEA country

Data set -

The downloadable data file is updated daily and contains the latest available public data on COVID-19. Each row/entry contains the number of new cases and deaths reported per day and per country in the EU/EEA.

Data

Data on COVID-19 vaccination in the EU/EEA

Data set -

The downloadable data files contain information on COVID-19 vaccination in the EU/EEA. The data are presented in the Vaccine Tracker and collected through The European Surveillance System (TESSy).

Publication

Risk assessment: The risk of variant Creutzfeldt-Jakob disease transmission via blood and plasma-derived medicinal products manufactured from donations obtained in the United Kingdom

Risk assessment -

ECDC assessed the risk to the EU/EEA of the presence and the possible transmission of prions, which have been linked to to Creutzfeldt-Jakob disease, by blood and plasma-derived medicinal products (PDMPs) manufactured from donations obtained in the UK.

The risk of variant Creutzfeldt-Jakob disease transmission via blood and plasma-derived medicinal products manufactured from donations obtained in the United Kingdom - EN - [PDF-727.45 KB]

Data

Data on country response measures to COVID-19

Data set -

This downloadable data file contains information on non-pharmaceutical interventions (or response measures) that countries in the EU/EEA have reported to date.